Sharron Gargosky - Concepedia

Author

Sharron Gargosky

Also Known As

S E Gargosky, S Gargosky, S. E. Gargosky, S. Gargosky, S.E. Gargosky, SHARRON E. GARGOSKY, Sharron E Gargosky, Sharron E. Gargosky, Sharron Erna Gargosky, Sharron Gargosky

115

Publications

3.8K

Citations

H-Index

130

Concepts

All Affiliations

Oregon Health & Science University Stanford University The University of Adelaide University of California, San Francisco University of California, Davis

About

Sharron Gargosky is an author at Oregon Health & Science University specializing in medicine, endocrinology, and human growth.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	34	1.9K
2	Public Health	9	9	671
3	Health Sciences	7	7	515
4	Natural Sciences	2	2	51
5	Education	1	1	130

Sharron Gargosky

Publications

Citations

H-Index

Page 1

	Year	Citations
Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. Linda C. Giudice, Francis de Zegher, Sharron Gargosky, The Journal of Clinical Endocrinology & Metabolism Human GrowthInsulin-like Growth FactorsFetal MedicineIntrauterine GrowthFetal Health	1995	363
Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Sharron Gargosky, Hung Pham, Kristin F. Wilson, Endocrinology	1992	141
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma Alain P. Algazi, Chris Twitty, Katy K. Tsai, Clinical Cancer Research	2020	139
A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. Jaime Guevara‐Aguirre, Oswaldo Vasconez, Víctor Martínez, The Journal of Clinical Endocrinology & Metabolism Metabolic SyndromeGrowth HormoneHuman GrowthGrowth RateInsulin Management	1995	130
Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients Alain P. Algazi, Shailender Bhatia, Sanjiv S. Agarwala, Annals of Oncology	2020	125
Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. M A Vaccarello, F Diamond, Jaime Guevara‐Aguirre, The Journal of Clinical Endocrinology & Metabolism Metabolic SyndromeImproved Growth VelocityGrowth HormoneEndocrine MechanismHuman Growth	1993	124
Two-Year Treatment of Growth Hormone (GH) Receptor Deficiency with Recombinant Insulin-Like Growth Factor I in 22 Children: Comparison of Two Dosage Levels and to GH-Treated GH Deficiency<sup>1</sup> Jaime Guevara‐Aguirre, Arlan L. Rosenbloom, Oswaldo Vasconez, The Journal of Clinical Endocrinology & Metabolism	1997	121
High-dose growth hormone treatment of short children born small for gestational age. Francis de Zegher, Michaël Maes, Sharron Gargosky, The Journal of Clinical Endocrinology & Metabolism NutritionShort StatureHuman GrowthHigh-dose Growth HormoneVelocity Sds	1996	107
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma Shailender Bhatia, Natalie V. Longino, Natalie Miller, Clinical Cancer Research	2019	88
Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. Takaaki Matsumoto, Sharron Gargosky, Ken‐ichi Iwasaki, The Journal of Clinical Endocrinology & Metabolism Human GrowthIgfbp-3 DoubletImmunologyPathologyOsteoporosis	1996	81

Page 1